Corrigendum to "Genome-engineering technologies for modeling and treatment of cystic fibrosis" [Adv Med Sci (2023 Sept) 68(1) 111-120]

Affiliations

¹ II Department of Lung Diseases and Tuberculosis, Medical of Bialystok, Bialystok, Poland. Electronic address: michal.debczynski@umb.edu.pl.
² II Department of Lung Diseases and Tuberculosis, Medical of Bialystok, Bialystok, Poland.
³ II Department of Lung Diseases and Tuberculosis, Medical of Bialystok, Bialystok, Poland; Institute of Genetics and Animal Biotechnology, Polish Academy of Sciences, Magdalenka, Poland; Department of Psychiatry, Charité - Universitätmedizin Berlin, Berlin, Germany; Berlin Institute for Medical Systems Biology (BIMSB), Max-Delbrück-Center for Molecular Medicine (MDC), Berlin, Germany.

Published Erratum

Michał Dębczyński et al. Adv Med Sci. 2025 Mar.

. 2025 Mar;70(1):229.

doi: 10.1016/j.advms.2025.01.009. Epub 2025 Feb 12.

¹ II Department of Lung Diseases and Tuberculosis, Medical of Bialystok, Bialystok, Poland. Electronic address: michal.debczynski@umb.edu.pl.
² II Department of Lung Diseases and Tuberculosis, Medical of Bialystok, Bialystok, Poland.
³ II Department of Lung Diseases and Tuberculosis, Medical of Bialystok, Bialystok, Poland; Institute of Genetics and Animal Biotechnology, Polish Academy of Sciences, Magdalenka, Poland; Department of Psychiatry, Charité - Universitätmedizin Berlin, Berlin, Germany; Berlin Institute for Medical Systems Biology (BIMSB), Max-Delbrück-Center for Molecular Medicine (MDC), Berlin, Germany.

No abstract available

Erratum for

Genome-engineering technologies for modeling and treatment of cystic fibrosis.
Dębczyński M, Mojsak D, Minarowski Ł, Maciejewska M, Lisowski P, Mróz RM. Dębczyński M, et al. Adv Med Sci. 2023 Mar;68(1):111-120. doi: 10.1016/j.advms.2023.02.003. Epub 2023 Mar 12. Adv Med Sci. 2023. PMID: 36917892 Review.